From groundbreaking information offered at ACC 2025 to rising developments, this webinar supplies an in-depth evaluation of the most recent information and key takeaways shaping the way forward for cardiovascular drug growth. Our panel of specialists examines novel therapeutic targets, biomarker-driven examine designs, and real-world proof methods that may assist sponsors seeking to optimize trial design and execution in an more and more aggressive area. Key discussions embrace:
Whether or not you’re advancing a first-in-human asset or scaling a world Part III program, watch on-demand to find real-world learnings to tell your subsequent steps in cardiovascular growth.
